64 related articles for article (PubMed ID: 38690512)
1. Bone marrow microenvironment: The guardian of leukemia stem cells.
Houshmand M; Blanco TM; Circosta P; Yazdi N; Kazemi A; Saglio G; Zarif MN
World J Stem Cells; 2019 Aug; 11(8):476-490. PubMed ID: 31523368
[TBL] [Abstract][Full Text] [Related]
2. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
Lefort S; Maguer-Satta V
Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
[TBL] [Abstract][Full Text] [Related]
3. Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC
Ai CJ; Chen LJ; Guo LX; Wang YP; Zhao ZY
World J Stem Cells; 2024 Apr; 16(4):444-458. PubMed ID: 38690512
[TBL] [Abstract][Full Text] [Related]
4. LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
Zhao Z; Sun Y; Tang J; Yang Y; Xu X
BMC Cancer; 2023 Oct; 23(1):935. PubMed ID: 37789316
[TBL] [Abstract][Full Text] [Related]
5. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-associated protein LRPPRC exerts cardioprotective effects against doxorubicin-induced toxicity, potentially via inhibition of ROS accumulation.
Tang Q; Xiong W; Ke X; Zhang J; Xia Y; Liu D
Exp Ther Med; 2020 Oct; 20(4):3837-3845. PubMed ID: 32855734
[TBL] [Abstract][Full Text] [Related]
7. Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
Cook AM; Li L; Ho Y; Lin A; Li L; Stein A; Forman S; Perrotti D; Jove R; Bhatia R
Blood; 2014 May; 123(18):2826-37. PubMed ID: 24668492
[TBL] [Abstract][Full Text] [Related]
8. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
[TBL] [Abstract][Full Text] [Related]
9. Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer.
Yang Y; Yuan H; Zhao L; Guo S; Hu S; Tian M; Nie Y; Yu J; Zhou C; Niu J; Wang G; Song Y
Cell Death Differ; 2022 Nov; 29(11):2177-2189. PubMed ID: 35484333
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene
Wang L; Luo J; Li Y; Lu Y; Zhang Y; Tian B; Zhao Z; Hu QY
Front Genet; 2021; 12():817672. PubMed ID: 35237297
[No Abstract] [Full Text] [Related]
11. LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis.
Wei WS; Wang N; Deng MH; Dong P; Liu JY; Xiang Z; Li XD; Li ZY; Liu ZH; Peng YL; Li Z; Jiang LJ; Yao K; Ye YL; Lu WH; Zhang ZL; Zhou FJ; Liu ZW; Xie D; Yu CP
Redox Biol; 2021 Nov; 48():102201. PubMed ID: 34864630
[TBL] [Abstract][Full Text] [Related]
12. FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML.
Chesnokov MS; Borhani S; Halasi M; Arbieva Z; Khan I; Gartel AL
Front Oncol; 2021; 11():696532. PubMed ID: 34381718
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML.
Sheng Y; Yu C; Liu Y; Hu C; Ma R; Lu X; Ji P; Chen J; Mizukawa B; Huang Y; Licht JD; Qian Z
Nat Commun; 2020 Feb; 11(1):928. PubMed ID: 32066721
[TBL] [Abstract][Full Text] [Related]
14. Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma.
Zhou W; Sun G; Zhang Z; Zhao L; Xu L; Yuan H; Li S; Dong Z; Song Y; Fang X
J Am Chem Soc; 2019 Nov; 141(46):18492-18499. PubMed ID: 31657561
[TBL] [Abstract][Full Text] [Related]
15. LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease.
Cui J; Wang L; Ren X; Zhang Y; Zhang H
Front Physiol; 2019; 10():595. PubMed ID: 31178748
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
